Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucroferric oxyhydroxide effect on calcification propensity in ESRD
NCT03010072Phase 2Completed
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iron sucrose in hyperphosphatemia. Started Jun 2017; status: completed.
02
Drugs
iron sucrose
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03010072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03010072.